Cargando…
Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients
Tyrosine kinase inhibitors (TKIs) are nowadays a valuable treatment of desmoid tumors, a rare mesenchymal neoplasm. Although many side effects of imatinib and pazopanib, commonly or rarely occurring, have been described, reactional lymphadenopathy has not yet been reported. In this publication, we r...
Autores principales: | Papadopoulos, Sotirios, Koulouris, Pantelis, Royer-Chardon, Claire, Tsoumakidou, Georgia, Dolcan, Ana, Cherix, Stephane, Matter, Maurice, Omoumi, Patrick, Digklia, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984282/ https://www.ncbi.nlm.nih.gov/pubmed/35399933 http://dx.doi.org/10.3389/fendo.2022.794512 |
Ejemplares similares
-
Cryoablation of Extra-Abdominal Desmoid Tumors: A Single-Center Experience with Literature Review
por: Saltiel, Sarah, et al.
Publicado: (2020) -
Optimal Delivery of Follow-Up Care Following Treatment for Adults Treated for Ewing Sarcoma
por: Digklia, Antonia, et al.
Publicado: (2023) -
Mediastinal Desmoid Tumor Presents as Lymphadenopathy in Patient with Lymphoma: A Case Report
por: Ballouz, Tara L., et al.
Publicado: (2023) -
BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality
por: Siddiqui, Sana, et al.
Publicado: (2013) -
Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase
por: Hubbard, Stevan R.
Publicado: (2018)